Entity Details

Primary name PLAU
Entity type gene
Source Source Link

Details

PrimaryID5328
RefseqGeneNG_011904
SymbolPLAU
Nameplasminogen activator, urokinase
Chromosome10
Location10q22.2
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-08-27
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsUROK_HUMAN

GO terms

Show/Hide Table
GOName
GO:0001666 response to hypoxia
GO:0004252 serine-type endopeptidase activity
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005886 plasma membrane
GO:0005925 focal adhesion
GO:0006508 proteolysis
GO:0006935 chemotaxis
GO:0007165 signal transduction
GO:0007596 blood coagulation
GO:0009986 cell surface
GO:0010469 regulation of signaling receptor activity
GO:0014909 smooth muscle cell migration
GO:0014910 regulation of smooth muscle cell migration
GO:0030335 positive regulation of cell migration
GO:0031639 plasminogen activation
GO:0033628 regulation of cell adhesion mediated by integrin
GO:0035579 specific granule membrane
GO:0042127 regulation of cell population proliferation
GO:0042730 fibrinolysis
GO:0043312 neutrophil degranulation
GO:0061041 regulation of wound healing
GO:0070062 extracellular exosome
GO:0070821 tertiary granule membrane
GO:2000097 regulation of smooth muscle cell-matrix adhesion

Diseases

Show/Hide Table
Disease IDSourceNameDescription
601709 OMIMQuebec platelet disorder (QPD)An autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins. The disease is caused by variants affecting the gene represented in this entry.